Need professional-grade analysis? Visit stockanalysis.com
$349.30M
N/A
N/A
N/A
Rezolute Inc (RZLT) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $3.46, down 2.26% from the previous close.
Over the past year, RZLT has traded between a low of $1.40 and a high of $10.94. The stock has gained 11.3% over this period. It is currently 68.4% below its 52-week high.
Rezolute Inc has a market capitalization of $349.30M.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Side-by-side comparison against top Healthcare peers.